ALEXANDRIA, Va., April 30 -- The trademark GLOBAL HAEMOPHILIA NETWORK BRINGING TRIALS TO LIFE (Reg. No. 3950137; International Reg. No 1052782) was issued on April 26 by the USPTO.
Owner: Novo Nordisk A/S LIMITED LIABILITY COMPANY DENMARK Novo All DK-2880 Bagsvaerd DENMARK.
The trademark application serial number 79087965 was filed on Aug. 17, 2010 and was registered on April 26.
The description of the mark registered is "The color(s) dark blue, light blue and grey is/are claimed as a feature of the mark. The mark consists of the wording "GLOBAL HAEMOPHILIA NETWORK" in a dark blue and light blue stylized font, above the wording "BRINGING TRIALS TO LIFE" in a grey stylized font."
Goods and Services: Printed publications, namely, newsletters in the field of haemophilia and printed scientific research reports presenting the results of studies and trials concerning haemophilia
Education services, namely, providing live and online training in the field of clinical studies and trials concerning haemophilia; arranging of educational meetings, namely, of conferences and seminars
Providing an Internet website featuring news and information in the field of clinical trials and scientific research studies within haemophilia
For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com
No comments:
Post a Comment